| Date Filed | Type | Description |
| 08/25/2023 |
4
| Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Sold 9,514 shares
@ $1.17, valued at
$11.1k
Sold 7,442 shares
@ $1.089, valued at
$8.1k
|
|
| 03/06/2023 |
4
| Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 398 shares
@ $1.31, valued at
$521.4 |
|
| 03/06/2023 |
4
| Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 570 shares
@ $1.31, valued at
$746.7 |
|
| 03/06/2023 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 510 shares
@ $1.31, valued at
$668.1 |
|
| 03/06/2023 |
4
| Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,703 shares
@ $1.31, valued at
$2.2k
|
|
| 02/08/2023 |
4
| Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 458 shares
@ $2.02, valued at
$925.2 |
|
| 02/08/2023 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 617 shares
@ $2.02, valued at
$1.2k
|
|
| 02/08/2023 |
4
| Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 681 shares
@ $2.02, valued at
$1.4k
|
|
| 02/08/2023 |
4
| Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,982 shares
@ $2.02, valued at
$4k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Afable Richard (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,500 shares
@ $0
Granted 31,000 options to buy
@ $0.2309, valued at
$7.2k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Rosen Howard B (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,500 shares
@ $0
Granted 31,000 options to buy
@ $0.2309, valued at
$7.2k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Bought 46,400 shares
@ $0.2227, valued at
$10.3k
|
|
| 03/04/2022 |
4
| Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 7,923 shares
@ $0.4068, valued at
$3.2k
|
|
| 03/04/2022 |
4
| Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 5,612 shares
@ $0.4068, valued at
$2.3k
|
|
| 03/04/2022 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 7,923 shares
@ $0.4068, valued at
$3.2k
|
|
| 03/04/2022 |
4
| Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 23,051 shares
@ $0.4068, valued at
$9.4k
|
|
| 02/14/2022 |
4
| Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 122,500 shares
@ $0
Paid exercise price by delivering 7,927 shares
@ $0.4014, valued at
$3.2k
Granted 245,000 options to buy
@ $0.4014, valued at
$98.3k
|
|
| 02/14/2022 |
4
| Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 97,500 shares
@ $0
Paid exercise price by delivering 5,615 shares
@ $0.4014, valued at
$2.3k
Granted 195,000 options to buy
@ $0.4014, valued at
$78.3k
|
|
| 02/14/2022 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 117,500 shares
@ $0
Paid exercise price by delivering 7,927 shares
@ $0.4014, valued at
$3.2k
Granted 235,000 options to buy
@ $0.4014, valued at
$94.3k
|
|
| 02/14/2022 |
4
| Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 390,000 shares
@ $0
Paid exercise price by delivering 23,058 shares
@ $0.4014, valued at
$9.3k
Granted 780,000 options to buy
@ $0.4014, valued at
$313.1k
|
|
| 02/07/2022 |
4
| Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,391 shares
@ $0.4312, valued at
$4k
|
|
| 02/07/2022 |
4
| Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 6,830 shares
@ $0.4312, valued at
$2.9k
|
|
| 02/07/2022 |
4
| ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,391 shares
@ $0.4312, valued at
$4k
|
|
| 02/07/2022 |
4
| Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 27,318 shares
@ $0.4312, valued at
$11.8k
|
|
| 11/23/2021 |
4
| Broadfoot Jill Marie (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $0.72, valued at
$21.6k
|
|
| 11/23/2021 |
3
| Broadfoot Jill Marie (Director) has filed a Form 3 on ACELRX PHARMACEUTICALS INC |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Rosen Howard B (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $1.41, valued at
$28.2k
|
|
|